Works matching AU Kevin, Richard C

Results: 21

An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-84897-w

By:

Zhou, Cilla;
Lavender, Isobel;
Gordon, Rebecca;
McCartney, Danielle;
Kevin, Richard C.;
Bedoya-Pérez, Miguel A.;
McGregor, Iain S.

Publication type:

Article

How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials.

Published in:

Drug Testing & Analysis, 2023, v. 15, n. 3, p. 334, doi. 10.1002/dta.3419

By:

McCartney, Danielle;
Kevin, Richard C.;
Suraev, Anastasia S.;
Sahinovic, Ayshe;
Doohan, Peter T.;
Bedoya‐Pérez, Miguel A.;
Grunstein, Ronald R.;
Hoyos, Camilla M.;
McGregor, Iain S.

Publication type:

Article

Orally administered cannabidiol does not produce false‐positive tests for Δ9‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.

Published in:

Drug Testing & Analysis, 2022, v. 14, n. 1, p. 137, doi. 10.1002/dta.3153

By:

McCartney, Danielle;
Kevin, Richard C.;
Suraev, Anastasia S.;
Irwin, Christopher;
Grunstein, Ronald R.;
Hoyos, Camilla M.;
McGregor, Iain S.

Publication type:

Article

A validated method for the simultaneous quantification of cannabidiol, Δ9‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open‐label trial.

Published in:

Drug Testing & Analysis, 2021, v. 13, n. 3, p. 614, doi. 10.1002/dta.2947

By:

Kevin, Richard C.;
Vogel, Rebecca;
Doohan, Peter;
Berger, Maximus;
Amminger, G. Paul;
McGregor, Iain S.

Publication type:

Article

Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices.

Published in:

Drug Testing & Analysis, 2019, v. 11, n. 10, p. 1486, doi. 10.1002/dta.2687

By:

Arkell, Thomas R.;
Kevin, Richard C.;
Stuart, Jordyn;
Lintzeris, Nicholas;
Haber, Paul S.;
Ramaekers, Johannes G.;
McGregor, Iain S.

Publication type:

Article

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F‐PY‐PICA, 5F‐PY‐PINACA, and their analogs.

Published in:

Drug Testing & Analysis, 2019, v. 11, n. 7, p. 976, doi. 10.1002/dta.2583

By:

Banister, Samuel D.;
Kevin, Richard C.;
Martin, Lewis;
Adams, Axel;
Macdonald, Christa;
Manning, Jamie J.;
Boyd, Rochelle;
Cunningham, Michael;
Stevens, Marc Y.;
McGregor, Iain S.;
Glass, Michelle;
Connor, Mark;
Gerona, Roy R.

Publication type:

Article

Synthesis and pharmacology of new psychoactive substance 5F‐CUMYL‐P7AICA, a scaffold‐ hopping analog of synthetic cannabinoid receptor agonists 5F‐CUMYL‐PICA and 5F‐CUMYL‐PINACA.

Published in:

Drug Testing & Analysis, 2019, v. 11, n. 2, p. 279, doi. 10.1002/dta.2491

By:

Banister, Samuel D.;
Adams, Axel;
Kevin, Richard C.;
Macdonald, Christa;
Glass, Michelle;
Boyd, Rochelle;
Connor, Mark;
McGregor, Iain S.;
Havel, Christopher M.;
Bright, Stephen J.;
Vilamala, Mireia Ventura;
Lladanosa, Cristina Gil;
Barratt, Monica J.;
Gerona, Roy R.

Publication type:

Article

The chemistry and pharmacology of synthetic cannabinoid SDB‐006 and its regioisomeric fluorinated and methoxylated analogs.

Published in:

Drug Testing & Analysis, 2018, v. 10, n. 7, p. 1099, doi. 10.1002/dta.2362

By:

Banister, Samuel D.;
Olson, Alexander;
Winchester, Matthew;
Stuart, Jordyn;
Edington, Amelia R.;
Kevin, Richard C.;
Longworth, Mitchell;
Herrera, Marco;
Connor, Mark;
McGregor, Iain S.;
Gerona, Roy R.;
Kassiou, Michael

Publication type:

Article

Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN‐18.

Published in:

Drug Testing & Analysis, 2018, v. 10, n. 1, p. 137, doi. 10.1002/dta.2262

By:

Kevin, Richard C.;
Lefever, Timothy W.;
Snyder, Rodney W.;
Patel, Purvi R.;
Gamage, Thomas F.;
Fennell, Timothy R.;
Wiley, Jenny L.;
McGregor, Iain S.;
Thomas, Brian F.

Publication type:

Article

The driving‐related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation.

Published in:

Drug & Alcohol Review, 2025, v. 44, n. 2, p. 588, doi. 10.1111/dar.13983

By:

McCartney, Danielle;
Zhou, Cilla;
Lavender, Isobel;
Gordon, Rebecca;
Kevin, Richard C.;
Bedoya‐Pérez, Miguel;
McGregor, Iain S.

Publication type:

Article

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.

Published in:

Psychopharmacology, 2019, v. 236, n. 9, p. 2713, doi. 10.1007/s00213-019-05246-8

By:

Arkell, Thomas R.;
Lintzeris, Nicholas;
Kevin, Richard C.;
Ramaekers, Johannes G.;
Vandrey, Ryan;
Irwin, Christopher;
Haber, Paul S.;
McGregor, Iain S.

Publication type:

Article

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.

Published in:

Journal of Psychopharmacology, 2022, v. 36, n. 12, p. 1338, doi. 10.1177/02698811221095356

By:

McCartney, Danielle;
Suraev, Anastasia S;
Doohan, Peter T;
Irwin, Christopher;
Kevin, Richard C;
Grunstein, Ronald R;
Hoyos, Camilla M;
McGregor, Iain S

Publication type:

Article

The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study.

Published in:

Traffic Injury Prevention, 2021, v. 22, n. 2, p. 102, doi. 10.1080/15389588.2020.1851685

By:

Arkell, Thomas R.;
Spindle, Tory R.;
Kevin, Richard C.;
Vandrey, Ryan;
McGregor, Iain S.

Publication type:

Article

Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial.

Published in:

Sports Medicine - Open, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40798-022-00417-y

By:

Sahinovic, Ayshe;
Irwin, Christopher;
Doohan, Peter T.;
Kevin, Richard C.;
Cox, Amanda J.;
Lau, Namson S.;
Desbrow, Ben;
Johnson, Nathan A.;
Sabag, Angelo;
Hislop, Matthew;
Haber, Paul S.;
McGregor, Iain S.;
McCartney, Danielle

Publication type:

Article

Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.

Published in:

2020

By:

Arkell, Thomas R.;
Vinckenbosch, Frederick;
Kevin, Richard C.;
Theunissen, Eef L.;
McGregor, Iain S.;
Ramaekers, Johannes G.

Publication type:

journal article

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy.

Published in:

Frontiers in Physiology, 2023, v. 14, p. 1, doi. 10.3389/fphys.2023.1086243

By:

Harman, Thomas;
Udoh, Michael;
McElroy, Dan L.;
Anderson, Lyndsey L.;
Kevin, Richard C.;
Banister, Samuel D.;
Ametovski, Adam;
Markham, Jack;
Bladen, Chris;
Doohan, Peter T.;
Greba, Quentin;
Laprairie, Robert B.;
Snutch, Terrance P.;
McGregor, Iain S.;
Howland, John G.;
Arnold, Jonathon C.

Publication type:

Article

Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice.

Published in:

Substance Abuse: Research & Treatment, 2017, n. 11, p. 1, doi. 10.1177/1178221817701739

By:

Lefever, Timothy W.;
Marusich, Julie A.;
Thomas, Brian F.;
Barrus, Daniel G.;
Peiper, Nicholas C.;
Kevin, Richard C.;
Wiley, Jenny L.

Publication type:

Article

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials.

Published in:

Addiction Biology, 2022, v. 27, n. 2, p. 1, doi. 10.1111/adb.13125

By:

Arkell, Thomas R.;
Kevin, Richard C.;
Vinckenbosch, Frederick;
Lintzeris, Nicholas;
Theunissen, Eef;
Ramaekers, Johannes G.;
McGregor, Iain S.

Publication type:

Article

Defensive Aggregation (Huddling) in Rattus Norvegicus toward Predator Odor: Individual Differences, Social Buffering Effects and Neural Correlates.

Published in:

PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068483

By:

Bowen, Michael T.;
Kevin, Richard C.;
May, Matthew;
Staples, Lauren G.;
Hunt, Glenn E.;
McGregor, Iain S.

Publication type:

Article

Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.

Published in:

2017

By:

Kevin, Richard C.;
Wood, Katie E.;
Stuart, Jordyn;
Mitchell, Andrew J.;
Moir, Michael;
Banister, Samuel D.;
Kassiou, Michael;
McGregor, Iain S.

Publication type:

journal article

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist.

Published in:

Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00595

By:

Kevin, Richard C.;
Anderson, Lyndsey;
McGregor, Iain S.;
Boyd, Rochelle;
Manning, Jamie J.;
Glass, Michelle;
Connor, Mark;
Banister, Samuel D.

Publication type:

Article

Works matching AU Kevin, Richard C

An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory.

How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials.

Orally administered cannabidiol does not produce false‐positive tests for Δ<sup>9</sup>‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.

A validated method for the simultaneous quantification of cannabidiol, Δ<sup>9</sup>‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open‐label trial.

Detection of Δ<sup>9</sup> THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices.

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F‐PY‐PICA, 5F‐PY‐PINACA, and their analogs.

Synthesis and pharmacology of new psychoactive substance 5F‐CUMYL‐P7AICA, a scaffold‐ hopping analog of synthetic cannabinoid receptor agonists 5F‐CUMYL‐PICA and 5F‐CUMYL‐PINACA.

The chemistry and pharmacology of synthetic cannabinoid SDB‐006 and its regioisomeric fluorinated and methoxylated analogs.

Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN‐18.

The driving‐related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation.

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.

The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study.

Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial.

Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy.

Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice.

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials.

Defensive Aggregation (Huddling) in <i>Rattus Norvegicus</i> toward Predator Odor: Individual Differences, Social Buffering Effects and Neural Correlates.

Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist.